Belrose Buys Enzon's Pegylation Platform and Drug Candidates
Drugmakers have been slow to adopt releasable PEGylation according to Belrose Pharma, which plans to use a tech it has bought from Enzon to expand the market.
Archives for June 19, 2013
Ash Stevens to Expand API Manufacturing Facility Over Next Decade
Ash Stevens is planning to expand its API manufacturing facility in Michigan, which was recently approved by the US FDA to produce Ariad Pharmaceuticals’ oncology drug Iclusig (ponatinib).
New SCM Facility to Begin Production After MHRA Approval
SCM Pharma says its new contract manufacturing facility will cater for clients upscaling towards commercial production and the trend towards orphan drugs.
Brazil's $280m Deal to Manufacture and Market Gaucher's Disease Drug
The Brazilian Government is to fund a new facility to produce the Protalix-Pfizer Gaucher's disease drug Uplyso as part of a supply and tech transfer deal worth $280m (€212m).
CRO Industry Could See More Consolidation, Experts Say
As private equity firms look to cash in on their investments, CROs could consolidate more, especially as the market for middle- and top-tier CROs gets more competitive, experts say.
Investment Analysts Offer Mostly Positive Outlook on Quintiles
More than ten top investment analysts initiated coverage on Quintiles this week and most gave the company either a neutral or positive outlook.